BGXX: Total Utang marang Modal Bright Green

Bright Green - logo grafis emiten BGXX

Bright Green (BGXX) operations are subject to DEA regulatory pressure and legal uncertainty, which is reflected in the price chart supporting the market valuation, where the individual debt-to-equity ratio is recorded at 0.05. The business relies on the cultivation and processing of raw materials for scientific and medical purposes; however, profit growth is constrained by the capital-intensive completion of greenhouses prior to obtaining trading permits.

Bright Green Corp. (BGXX): Rasio Kabeh Utang marang Dana Pribadi saka 28.04.2023 nganti 21.09.2024

Rincian metrik lan analitis perusahaan Bright Green Corporation (BGXX)

- rega lan prakiraan konsensus rega:
Bagan rega Bright Green Corp.|BGXX - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Bright Green|BGXX - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham Bright Green|BGXX - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku brightgreen.us|BGXX - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Ekuitas Bright Green|BGXX - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Bright Green Corp.|BGXX - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Bright Green|BGXX - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Bright Green|Likuiditas cepet brightgreen.us
- data bathi resik lan rasio valuasi:
BGXX - Bathi pungkasan
Pambiji fundamental perusahaan:Bright Green, BGXX
Barang utama Bright Green Corp

This ratio determines the degree of financial leverage by comparing total liabilities to net assets to assess the business's dependence on borrowed capital. Analyzing the total debt-to-equity chart, an investor can see how the debt load of Bright Green (BGXX) adapts to regulatory cycles and pharmaceutical cannabis licensing, which critically impacts the company's stability during its formative period.

Karo sapa Bright Green saingan

Utang marang Ekuitas Indivior|Rasio Utang marang Ekuitas COLL (Collegium Pharma)|Total Utang marang Modal CRON|Total Utang marang Modal Canopy Growth Corp. (CGC)|Utang marang Ekuitas High Tide Inc. HITI|Rasio Kabeh Utang marang Dana Pribadi ACB|Achieve Life Sciences, Inc. - Total Utang marang Modal|Skye Bioscience Inc. (SKYE) - Rasio Total Utang marang Ekuitas|Anebulo (ANEB) - Utang marang Ekuitas|Utang marang Modal InterCure (INCR)|Rasio Total Utang marang Ekuitas NTRB|NSRX: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal IGC|MIRA: Utang Agregat marang Ekuitas|Total Utang marang Modal FLGC (Flora Growth Corporation)|Total Utang marang Modal IM Cannabis Corp IMCC|ADIL - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ARTL (Artelo Biosciences)|ensysce.com (ENSC) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Titan Pharmaceuticals, Inc.|GNLN (Greenlane Holdings Inc) - Total Utang marang Modal|Utang marang Ekuitas INM|Utang marang Ekuitas Akanda (AKAN)|ENVB (enveric.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HPCO (Hempacco Co., Inc.)